Vimta Labs Limited — Others, 06-06-2025: Appointment

VimtaLabs has announced a board meeting concerning the re-appointment of Dr. Yadagiri R Pendri as an independent director for a second and final five-year term starting August 2025. With over 35 years in pharmaceutical R&D, including leadership at Escientia Lifesciences, Dr. Pendri adds strong expertise in drug development and strategic business management. His re-appointment enhances the board’s capabilities in pharma innovation and supports the company’s growth plans.